Expiration date: 09/2025

Release form and composition:

Tablet, coated (transparent) from light brown to dark brown, with specks, round, lenticular, with the dividing mark on one side allowed the presence of a specific smell.

1 tablet contains:

dry standardized extract of Ginkgo biloba leaves 60 mg,

EMCO corresponds to the content of flavone glycosides 24% 14.4 mg

Excipients: calcium phosphate, microcrystalline cellulose, stearic acid, sodium croscarmellose, magnesium stearate, silicon dioxide.

The composition of the shell of the tablets: hypromellose, triacetin.

10 PCs. - blisters (3) - packs cardboard.

10 PCs. - blisters (6) - packs cardboard.

30 PCs. - bottles plastic (1) - packs of cardboard.

60 PCs. - bottles plastic (1) - packs of cardboard.

Pharmacological action:

The drug of plant origin. Improves cerebral blood circulation and supply the brain with oxygen and glucose, normalizes metabolism in cells, blood rheology and microcirculation. Has a regulating effect on the vascular system, expanding the small arteries, increases venous tone, thereby regulating blood vessels. Lets tromboobrazovaniu, has a decongestant effect (brain, peripheral tissues), normalizes neurotransmitter processes in the CNS.

Provides antihypoxia action, improves memory and learning ability, stimulates brain activity.

Pharmacokinetics:

Data on the pharmacokinetics of the drug after Its application is not granted.

Indications:

• decrease in attention, memory, quick thinking, and deterioration of intellectual abilities, hearing, vision, speech functions (including the result of age-related changes )
  
• in the treatment of disorders of peripheral circulation and microcirculation of the lower extremities.
  

Dosing regimen:

The drug is prescribed inside, during meal, 1 tab. 2 times/day. The average duration of treatment - 3 months. Repeated courses are possible after consultation with the doctor.

Side effects:

Possible: dyspepsia, headache, allergic skin reactions, dizziness.

Contraindications:

• anticoagulation
  
• acute disorders of cerebral circulation
  
• acute myocardial infarction
  
• peptic ulcer of stomach and duodenum
  
• erosive gastritis
  
• hypotension
  
• pregnancy
  
• lactation (breast feeding)
  
• children's age
  
• hypersensitivity to the drug.
  

Pregnancy and lactation:

The drug is contraindicated during pregnancy and breastfeeding.

Special instructions:

Improvement is manifested, usually 1 month after start of treatment.

Avoid combination with acetylsalicylic acid and anticoagulants.

Overdose:

Currently, the cases of drug overdose after Its application were not reported.

Drug interactions:

Drug interactions drug after Its application is not described.

Terms and conditions of storage:

The drug should be stored in a dry, inaccessible for children place at temperature from 10° to 30°C. shelf Life – 3 years.